DMD and cardiac hypertrophy: To our knowledge, Dmd Δ52-54 is the first mouse model carrying a Dmd deletion mutation to exhibit early onset of a dystrophic cardiac phenotype and cardiac functional abnormalities, as shown through fibrotic development, ventricular hypertrophy and tachycardia.